Transforming growth factor-beta-induced factor 1 (TGIF1)

Transforming growth factor-beta-induced factor 1 (TGIF1) is a homeodomain-containing transcriptional corepressor that plays a pivotal role in modulating the TGF-beta signaling pathway (UniProt Q15583). It functions by binding to Smad2 and Smad3 proteins, thereby preventing their association with p300 co-activators and recruiting histone deacetylases (HDACs) to repress gene expression (PubMed 10391249). In adipose-derived stem cells (ASCs), TGIF1 expression is a critical regulator of the balance between self-renewal and differentiation, particularly influencing the transition between adipogenic and osteogenic lineages (PubMed 25650100). Mutations in the TGIF1 gene are linked to holoprosencephaly type 4, a severe developmental defect of the forebrain and face (PubMed 11146550). Additionally, TGIF1 is often overexpressed in various malignancies, such as colorectal and pancreatic cancers, where it contributes to tumor progression by antagonizing the growth-inhibitory effects of TGF-beta (PubMed 22431511). While no direct TGIF1 inhibitors are currently in clinical use, the molecule is a significant target for research in regenerative medicine and oncology due to its central role in cell fate determination.

Other names

TGIFHPE4Homeobox protein TGIF15'-TG-3'-interacting factor 1

TGIF1 functions as a transcriptional corepressor by binding to Smad2/3 complexes, which prevents their association with p300 co-activators and recruits histone deacetylases (HDACs) to repress TGF-beta responsive genes.